MAPT and early-onset autosomal dominant Alzheimer disease: Where tau pathology was sufficiently extensive to make western blotting possible (in patients #30 and 35) this produced a banding pattern consistent with Alzheimer’s disease, and neurofibrillary changes were detected by 3-R and 4-R tau immunostaining, again consistent with (an evolving) Alzheimer’s disease pathology.